Gilead Sciences, Inc. (GILD) EPCLUSA Access To Be Provided In Ontario For Treatment Of Hepatitis C
Public access for Gilead Sciences, Inc. (NASDAQ:GILD) EPCLUSA will be provided in Ontario to adults who need the drug for the hepatitis C treatment.
Posts Tagged ‘Is GILD A Good Stock To Buy Right Now?’
Losses and Gains For Gilead Sciences, Inc. (GILD) Under President Trump Expected
There are almost too many speculations of changes to come in Washington, D.C.
Federal Judge Orders State Provide Mumia Abu-Jamal With HCV Treatment by Gilead Sciences, Inc. (GILD)
A federal judge in Pennsylvania has admonished the state for restricting inmates’ access to drugs and particularly those for hepatitis C.
Spring Bank Pharmaceuticals Inc (SBPH) An Ace Up Gilead Sciences, Inc. (GILD)’s Sleeve
While most westerners don’t have to worry about hepatitis B virus (HBV) due to currently available and effective vaccines, HBV is still an incurable disease, with a staggering...
Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences, Inc.
GlaxoSmithKline PLC (ADR) (GSK) Phase 3 Trials Looks Positive: Will Gilead Sciences, Inc. (GILD) Endure?
Efforts by GlaxoSmithKline plc (ADR) (NYSE:GSK) in carrying out a large study on its new HIV drug are yielding positive results.
AbbVie Inc (ABBV) Awaits NDA Approval For Hepatitis C Treatment
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration.
Performance Of The Magic Formula Portfolio
Here’s a breakdown on how the Magic Formula Portfolio is performing.
Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns six stocks and is 60% invested.
The return on the invested capital is 5.
Gilead Sciences, Inc. (GILD) Begins A Process That Could Alleviate Its Problems
Gilead Sciences, Inc. (NASDAQ:GILD) has switched course and has begun aggressive marketing of its HIV drug Truvada as a preventative medicine for HIV-negative healthy people.
Gilead Sciences, Inc. (GILD) Takes Lead Against AbbVie Inc (ABBV) On Crohn’s Disease Treatment
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (NASDAQ:GLPG).
Matinas BioPharma Holdings Inc (MTNB) Can Take A $350M Antifungal Market From Gilead Sciences, Inc. (GILD)
In most cases a new method of drug delivery can occasionally alter markets a bit and cause some shifts. In rare cases though, it can fundamentally change an entire sector.
US Stock Charts And Ideas: Amazon (AMZN), Gilead (GILD), More
Today, I’m going to post some charts on a few trade setups that I’m focused on and which may provide a trade or two over the coming sessions.
